ABSTRACT
No disponible
Subject(s)
Rotavirus Infections/economics , Rotavirus Infections/epidemiology , Costs and Cost Analysis/economics , Mass Vaccination/economics , Vaccination/economics , Diarrhea/economics , Diarrhea, Infantile/economics , Health Care Costs/trends , Cost of Illness , Prospective StudiesABSTRACT
Heliox therapy, alone or combined with noninvasive ventilation, has successfully been used in the treatment of infants and children with respiratory disease such as airway obstruction. We describe the case of a 1-month-old infant with severe upper respiratory airway obstruction (approximately 80 %) secondary to multiple cervical hemangiomatosis effectively treated with either Heliox alone or combined with nasal continuous positive airway pressure. This treatment provided symptomatic relief and facilitated diagnosis and subsequent application of specific treatment; the patient was free of signs of respiratory distress and the use of aggressive treatments such as endotracheal intubation or tracheal cannulation was avoided. Heliox can constitute a multipurpose, safe and useful tool in the noninvasive management of infants and children with serious obstructive respiratory disease.
Subject(s)
Airway Obstruction/etiology , Airway Obstruction/therapy , Glottis , Helium/therapeutic use , Hemangioma/complications , Laryngeal Neoplasms/complications , Oxygen/therapeutic use , Respiration, Artificial , Combined Modality Therapy , Female , Humans , Hypoxia/physiopathology , Infant , Severity of Illness IndexABSTRACT
El Heliox, administrado solo o en combinación con ventilación no invasiva, se ha empleado con éxito en el tratamiento de niños con patología respiratoria de carácter obstructivo. Presentamos el caso de una lactante de un mes de edad con hemangiomatosis cervical múltiple y una obstrucción severa (aproximadamente del 80 %) de la vía aérea, en la que la administración de Heliox, solo o en combinación con presión positiva en la vía aérea nasal, permitió su manejo y alivio sintomático, facilitó su evaluación diagnóstica y la instauración posterior de tratamiento electivo, manteniéndola en todo momento libre de signos de dificultad respiratoria y evitando la instauración de tratamientos inespecíficos más agresivos tales como la intubación o la canulación traqueal. El Heliox puede constituir una herramienta polivalente, segura y útil en el manejo conservador de niños con patología respiratoria obstructiva grave
Heliox therapy, alone or combined with noninvasive ventilation, has successfully been used in the treatment of infants and children with respiratory disease such as airway obstruction. We describe the case of a 1-month-old infant with severe upper respiratory airway obstruction (approximately 80 %) secondary to multiple cervical hemangiomatosis effectively treated with either Heliox alone or combined with nasal continuous positive airway pressure. This treatment provided symptomatic relief and facilitated diagnosis and subsequent application of specific treatment; the patient was free of signs of respiratory distress and the use of aggressive treatments such as endotracheal intubation or tracheal cannulation was avoided. Heliox can constitute a multipurpose, safe and useful tool in the noninvasive management of infants and children with serious obstructive respiratory disease
Subject(s)
Male , Infant , Humans , Helium/therapeutic use , Hemangioma/therapy , Respiration, Artificial/methods , Helium/administration & dosage , Hemangioma/diagnosis , Pulmonary Disease, Chronic Obstructive/therapy , Intubation/methodsABSTRACT
Encephalocraniocutaneous lipomatosis, or Haberland syndrome, is an unusual form of neurocutaneous syndrome. Clinically, this syndrome is characterized by unilateral lipomatous hamartomas on the scalp and face, ocular damage and ipsilateral malformations of the central nervous system. First described by Haberland and Perou in 1970, only about 40 cases have been reported to date. The differential diagnoses with other neurocutaneous mosaicisms such as Delleman, Goltz, Goldenhar or Proteus syndrome may entail some degree of difficulty due to overlapping features. We report a case of Haberland syndrome in a neonate with bilateral ocular damage, illustrating the wide heterogeneity of this syndrome.
Subject(s)
Lipomatosis/diagnosis , Neurocutaneous Syndromes/diagnosis , Diagnosis, Differential , Eye Abnormalities , Humans , Infant, Newborn , MaleABSTRACT
La lipomatosis encefalocraneocutánea o síndrome de Haberland es una forma muy poco frecuente de síndrome neurocutáneo. Clínicamente se caracteriza por hamartomas lipomatosos en cara y cuero cabelludo, afectación ocular y malformaciones del sistema nervioso central ipsolaterales. Descrito por primera vez por Haberland y Perou en 1970, existen hasta la fecha unos 40 casos descritos. El diagnóstico diferencial con otros mosaicismos neurocutáneos como los síndromes de Delleman, Goltz, Goldenhar o Proteus puede llegar a ser muy dificultoso debido a la gran superposición que existe entre ellos. Presentamos el caso de un neonato con síndrome de Haberland con afectación ocular bilateral, mostrando la gran heterogeneidad clínica de este cuadro
Encephalocraniocutaneous lipomatosis, or Haberland syndrome, is an unusual form of neurocutaneous syndrome. Clinically, this syndrome is characterized by unilateral lipomatous hamartomas on the scalp and face, ocular damage and ipsilateral malformations of the central nervous system. First described by Haberland and Perou in 1970, only about 40 cases have been reported to date. The differential diagnoses with other neurocutaneous mosaicisms such as Delleman, Goltz, Goldenhar or Proteus syndrome may entail some degree of difficulty due to overlapping features. We report a case of Haberland syndrome in a neonate with bilateral ocular damage, illustrating the wide heterogeneity of this syndrome
Subject(s)
Male , Infant, Newborn , Humans , Lipomatosis/diagnosis , Neurocutaneous Syndromes/diagnosis , Eye Neoplasms/diagnosis , Neurocutaneous Syndromes/etiology , Hamartoma/diagnosis , Hamartoma/etiology , Face , Scalp , Diagnosis, Differential , Dermoid Cyst/etiology , Eye Neoplasms/etiologyABSTRACT
Se presenta el caso de un niño que al año de vida fue diagnosticado y tratado de infección por Helicobacter pylori. Ingresó en 3 ocasiones entre los 8 y 11 meses de vida en el servicio de lactantes por rechazo a la alimentación, estreñimiento pertinaz y desnutrición de grado III. En las analíticas y pruebas realizadas se descartaron las causas más frecuentesde malabsorción intestinal a esta edad. En el último ingreso, a los 11 meses de edad, se diagnosticó gastritis crónica activa y sensibilización a alimentos, la determinación de antígeno de H.pylori en heces y mucosa gástrica fue positiva. Se instauró tratamiento con triple terapia y dieta exenta de alimentos a los que el niño había demostrado sensibilización. Asimismo, senecesitó administrar la alimentación por sonda nasogástrica dado el rechazo total oral a la misma. El paciente evolucionó de forma favorable
The authors describe the diagnosis and treatment of Helicobacter pylori infection in a one-year-old infant. He was admitted to the infant unit three times between the ages of 8 and 11 months because of his refusal to eat, persistent constipation and grade III malnutrition. The results of the analyses and tests performed ruled out the most common causes of intestinal malabsorption in a child of that age. During the last hospital stay, at the age of 11 months, he was diagnosed as having chronic active gastritis and food hypersensitivity, and the tests for H. pylori in feces and gastric mucosa were positive. He was treated with triple therapy and a diet from which the foods to which he was sensitized were eliminated. He required nasogastric feeding because of his refusal of all oral nutrition, and the outcome was favorable
